Abstract: The invention relates to supplying vaccine RNA to cells. The invention relates in particular to a common use of vaccine RNA and Flt3 ligand for inducing, creating or enhancing an immune response when administered to animals (including humans).
Type:
Grant
Filed:
December 9, 2009
Date of Patent:
November 8, 2016
Assignees:
BioNTech AG, TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg—Universität Mainz gemeinnützige GmbH
Inventors:
Ugur Sahin, Özlem Türeci, Sebastian Kreiter, Abderraouf Selmi